Diapin is a clinical-stage pharmaceutical company developing novel therapeutics for the treatment of Stroke, Myocardial Infarction, NASH, Primary Biliary Cholangitis, Familial Partial Lipodystrophy, and Type 2 Diabetes.
Looking for a particular DIAPIN THERAPEUTICS employee's phone or email?
The DIAPIN THERAPEUTICS annual revenue was $1 million in 2026.
Jessica Reed is the CEO of DIAPIN THERAPEUTICS.
3 people are employed at DIAPIN THERAPEUTICS.
DIAPIN THERAPEUTICS is based in Northville, Michigan.
The NAICS codes for DIAPIN THERAPEUTICS are [54, 54171, 541, 541714, 5417].
The SIC codes for DIAPIN THERAPEUTICS are [873, 87].